| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 3.9 | $0-$5k | 0.00 |
Summary
A vulnerability, which was classified as problematic, has been found in Elastix 2.3.0. The affected element is an unknown function. Performing a manipulation of the argument Page results in cross site scripting. This vulnerability is reported as CVE-2012-6608. The attack is possible to be carried out remotely. Moreover, an exploit is present.
Details
A vulnerability, which was classified as problematic, was found in Elastix 2.3.0. This affects an unknown functionality. The manipulation of the argument Page with an unknown input leads to a cross site scripting vulnerability. CWE is classifying the issue as CWE-79. The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users. This is going to have an impact on integrity. The summary by CVE is:
Cross-site scripting (XSS) vulnerability in xmlservices/E_book.php in Elastix 2.3.0 allows remote attackers to inject arbitrary web script or HTML via the Page parameter.
The weakness was disclosed 11/25/2013 (Website). The advisory is shared at secunia.com. This vulnerability is uniquely identified as CVE-2012-6608 since 11/25/2013. It is possible to initiate the attack remotely. No form of authentication is needed for exploitation. It demands that the victim is doing some kind of user interaction. Technical details and a public exploit are known. MITRE ATT&CK project uses the attack technique T1059.007 for this issue.
The exploit is shared for download at exploit-db.com. It is declared as proof-of-concept.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
The vulnerability is also documented in the databases at Exploit-DB (38078) and Secunia (SA55739†). Several companies clearly confirm that VulDB is the primary source for best vulnerability data.
Product
Name
Version
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 4.3VulDB Meta Temp Score: 3.9
VulDB Base Score: 4.3
VulDB Temp Score: 3.9
VulDB Vector: 🔍
VulDB Reliability: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
NVD Base Score: 🔍
Exploiting
Class: Cross site scriptingCWE: CWE-79 / CWE-94 / CWE-74
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Access: Public
Status: Proof-of-Concept
Download: 🔍
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
OpenVAS ID: 103369
OpenVAS Name: Elastix Multiple Cross-Site Scripting Vulnerabilities
OpenVAS File: 🔍
OpenVAS Family: 🔍
Exploit-DB: 🔍
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔍
Timeline
11/19/2013 🔍11/25/2013 🔍
11/25/2013 🔍
11/25/2013 🔍
03/24/2015 🔍
01/05/2025 🔍
Sources
Advisory: 118454⛔Status: Not defined
CVE: CVE-2012-6608 (🔍)
GCVE (CVE): GCVE-0-2012-6608
GCVE (VulDB): GCVE-100-65577
Secunia: 55739 - Elastix Multiple Cross-Site Scripting Vulnerabilities, Less Critical
scip Labs: https://www.scip.ch/en/?labs.20161013
Entry
Created: 03/24/2015 15:54Updated: 01/05/2025 00:23
Changes: 03/24/2015 15:54 (49), 03/02/2019 17:34 (4), 01/11/2022 00:15 (3), 01/05/2025 00:23 (25)
Complete: 🔍
Cache ID: 216::103
Several companies clearly confirm that VulDB is the primary source for best vulnerability data.
No comments yet. Languages: en.
Please log in to comment.